Marshall Wace LLP Increases Stake in Mettler-Toledo International Inc. (NYSE:MTD)

Marshall Wace LLP lifted its holdings in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 34.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 107,524 shares of the medical instruments supplier's stock after purchasing an additional 27,280 shares during the period. Marshall Wace LLP owned about 0.51% of Mettler-Toledo International worth $131,575,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently bought and sold shares of the company. JPMorgan Chase & Co. increased its holdings in Mettler-Toledo International by 14.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier's stock worth $332,634,000 after acquiring an additional 28,478 shares in the last quarter. M&T Bank Corp raised its position in shares of Mettler-Toledo International by 14.3% during the 3rd quarter. M&T Bank Corp now owns 4,926 shares of the medical instruments supplier's stock worth $7,387,000 after purchasing an additional 615 shares during the last quarter. Allworth Financial LP lifted its stake in Mettler-Toledo International by 367.4% in the 4th quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier's stock valued at $285,000 after buying an additional 169 shares in the last quarter. Nordea Investment Management AB boosted its holdings in Mettler-Toledo International by 29.8% in the 4th quarter. Nordea Investment Management AB now owns 105,823 shares of the medical instruments supplier's stock worth $129,919,000 after buying an additional 24,285 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. increased its stake in Mettler-Toledo International by 18.0% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 34,370 shares of the medical instruments supplier's stock worth $42,058,000 after buying an additional 5,234 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

Mettler-Toledo International Price Performance

Shares of MTD traded down $11.93 during mid-day trading on Friday, reaching $1,004.72. The stock had a trading volume of 212,078 shares, compared to its average volume of 140,447. The business's fifty day moving average is $1,185.43 and its 200 day moving average is $1,261.60. Mettler-Toledo International Inc. has a 52-week low of $946.69 and a 52-week high of $1,546.93. The firm has a market cap of $20.94 billion, a price-to-earnings ratio of 24.79, a P/E/G ratio of 3.30 and a beta of 1.28.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. As a group, sell-side analysts anticipate that Mettler-Toledo International Inc. will post 42.71 EPS for the current fiscal year.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 600 shares of the business's stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total value of $810,804.00. Following the sale, the insider now owns 6 shares of the company's stock, valued at $8,108.04. The trade was a 99.01 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Christian Magloth sold 790 shares of the firm's stock in a transaction on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the transaction, the insider now owns 734 shares of the company's stock, valued at approximately $964,248.46. This represents a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the company. Robert W. Baird lifted their price target on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a "neutral" rating in a research note on Monday, February 10th. Wells Fargo & Company lowered their target price on shares of Mettler-Toledo International from $1,400.00 to $1,125.00 and set an "equal weight" rating on the stock in a research note on Thursday. Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price for the company in a research report on Monday, April 7th. Finally, Evercore ISI boosted their price target on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an "outperform" rating in a research report on Monday, February 10th. One analyst has rated the stock with a sell rating, five have issued a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Hold" and an average target price of $1,346.13.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.